checkAd
    Longboard Pharmaceuticals Aktie
    17,660
     
    USD
    +0,63 %
    +0,110 USD
    Letzter Kurs 20:53:51 Nasdaq
    17,620
     
    USD
    100 STK
    Geldkurs 20:56:39
    17,680
     
    USD
    400 STK
    Briefkurs 20:56:39
    ISIN: US54300N1037 · WKN: A2QQZ6 · SYM: LBPH · USA

    Neueste Nachrichten

    Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
    15:00 Uhr · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    03.06.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    06.05.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    02.05.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
    03.04.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    02.04.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
    12.03.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Cardiol Therapeutics, Defence Therapeutics, Immuron, Longboard Pharmaceuticals: Wertsteigerungen über Nacht
    07.03.24 · inv3st.de · ImmuronAnzeige
    Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    01.03.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    02.02.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
    01.02.24 · Business Wire (engl.) · Longboard Pharmaceuticals
    Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    08.01.24 · Business Wire (engl.) · Longboard Pharmaceuticals